Adverse Events and Recalls

Voluntary Nationwide Recall of Brimonidine Tartrate Ophthalmic Solution, 0.15%

March 06, 2023

Any patients who have received the identified lots or have any questions regarding the recall should contact their pharmacy or immediately contact a health provider in terms of medical advice.

Spectrum Laboratory Products Issues Recall of Epinephrine USP Bulk API Due to Discoloration

January 11, 2023

Epinephrine is a critical medication used during life-threatening conditions that can affect any age and any person.

Pfizer Issues Voluntary Nationwide Recall of Lots of Accupril

April 25, 2022

Pfizer has issued a voluntary nationwide recall of lots of Accupril due to N-nitroso-quinapril content.

Mylan Pharmaceuticals Issues Voluntary Recall of Insulin Glargine Injection

April 15, 2022

Mylan Pharmaceuticals is issuing a voluntary recall of one batch of insulin glargine injection due to the potential for a missing label in the batch.

Teva Issues Voluntary Nationwide Recall of IDArubicin Hydrochloride Injection USP 5 mg/5 mL

April 08, 2022

Teva has initiated a voluntary nationwide recall of one lot of IDArubicin Hydrochloride Injection USP 5mg/5 mL due to the presence of particulate matter.

Pfizer Issues Voluntary Recall of Blood Pressure Tablets Due to High Levels of Nitrosamine

March 30, 2022

Pfizer has issued a voluntary nationwide recall on lots of Accuretic tablets due to high levels of nitrosamine.

Olympia Pharmacy Issues Voluntary Nationwide Recall of Seven Compounded Products

March 21, 2022

Olympia Pharmacy is voluntarily recalling eleven lots of seven compounded products due to out-of-specification results.

Mylan Recalls Semglee Prefilled Pens

January 21, 2022

The company is voluntarily recalling one batch of Semglee prefilled pens because of a potential missing label.

Lohxa Recalls Senna Syrup

January 19, 2022

The company is voluntarily recalling one lot of Senna Syrup 8.8mg/5mL, unit-dose cups because of microbial contamination.

Pfizer Expands Varenicline (Chantix) Recall, But Drug Shortages Remain a Concern

September 17, 2021

Pfizer has expanded its voluntary recall to include all lots of varenicline (Chantix), but FDA allows continued distribution of the drug product to continue due to drug shortages.